Back

MYL2 reporter line allows purification of ventricular human iPSC induced cardiomyocytes

28 August 2018 (14:00 - 18:00)
Organised by:
Congress Presentation Part of: Best Posters 7 - Best Posters in heart and vascular development Stem Cells, Cell Cycle, Cell Senescence, Cell Death ESC Premium Access ESC Congress 2018

About the speaker

Photo
Doctor Elda Dzilic

German Heart Center of Munich, Munich (Germany)

4 More presentations in this session

Presentation thumbnail
Presentation thumbnail
Doctor C. Tsai (Taipei, TW)
Abstract
Presentation thumbnail
Professor H. Cho (Seoul, KR)
Abstract
Presentation thumbnail
Doctor Y. Liu (New Taipei, TW)
Abstract

Access the full session

Session thumbnail
Best Posters 7 - Best Posters in heart and vascular development

The Event

Event poster

ESC Congress 2018

28 August 2018 14:00 CET
You may be interested in
thumbnail
Congress Session
Novel mechanisms in arrhythmogenic cardiac diseases
2 September 2024
thumbnail
Congress Presentation
Safety and efficacy of induced pluripotent stem cell-derived engineered human myocardium as biological ventricular assist tissue in term. heart failure (BioVAT-HF):trial design and experience at UKSH
21 May 2023
thumbnail
Congress Presentation
Maturing hiPSC-cardiomyocytes in cardiac microtissues for accurate preclinical in vitro modelling of long-QT syndrome type 1
12 April 2024
thumbnail
Webinar
Induced-pluripotent stem cells (iPSC) technology for cardiac repair
17 March 2022

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources